Concurrent phase I trials of intravenous interleukin 6 in solid tumor patients: reversible dose-limiting neurological toxicity.

Sosman JA, Aronson FR, Sznol M, Atkins MB, Dutcher JP, Weiss GR, Isaacs RE, Margolin KA, Fisher RI, Ernest ML, Mier J, Oleksowicz L, Eckhardt JR, Levitt D, Doroshow JH
Clin Cancer Res. 1997 3 (1): 39-46

PMID: 9815535

MeSH Terms (14)

Adult Aged Antineoplastic Agents Cohort Studies Dose-Response Relationship, Drug Female Humans Injections, Intravenous Interleukin-6 Male Middle Aged Neoplasms Neurons Treatment Outcome

Connections (1)

This publication is referenced by other Labnodes entities:

Links